Elucigene Diagnostics, developer and manufacturer of leading prenatal and human genetics diagnostics have partnered with Southern Cross Diagnostics to service their growing customer base in Australia and New Zealand. Elucigene Diagnostics’ range of high-quality and innovative test kit for rapid aneuploidy analysis, reproductive health, and single gene disorders are CE-IVD marked and TGA approved.
The Southern Cross team have more than 30 years’ experience in the human diagnostic and medical device industry in Australia. Southern Cross Diagnostics aims to provide both quality products and a service that is industry leading in both standard and support. SCD have been operating from Sydney since 2008 and are a specialised Diagnostics company focusing mainly on Infectious disease and molecular diagnostics.
“At SCD we are very excited to be able to work with Elucigene to bring these cutting edge prenatal and human genetics diagnostics to the Australian and New Zealand markets. Elucigine is a leader in their field and we look forward to providing their existing portfolio of products as well as their new products planned for release in the future.”
Dr Mark Street-Docherty, Sales and Marketing Director of Elucigene Diagnostics says “We are excited to have partnered with Southern Cross Diagnostics in order to provide new and existing customers in the region with the very best customer service”.
Southern Cross Diagnostics will now offer local sales and marketing support to customers, including local delivery of the Elucigene product range across Australasia. Dr Erinn Ogg of Elucigene Diagnostics will continue to provide dedicated remote and on-site technical support alongside the Southern Cross Diagnostics team.
Elucigene products will be offered through the partnership from April 10 2017, interested parties should visit www.scdiagnostics.com.au for more detailed information.
About Elucigene Diagnostics Ltd
Elucigene Diagnostics (Manchester, UK) is a leading molecular diagnostics design, manufacture, and distribution company, offering a suite of in vitro diagnostic CE marked products for prenatal, rare disease, and infertility genetic diagnosis. Elucigene aims to provide customers with products that enable clarity of clinical utility without complexity in sample processing and analysis.